Key result
Ox-LDL-regulated miRNAs emerge as potential biomarkers and therapeutic targets for endothelial dysfunction in atherosclerosis.
Why the study?
Oxidized LDL contributes to atherosclerosis through endothelial dysfunction, and the role of ox-LDL-regulated microRNAs as biomarkers and molecular mediators in this process requires investigation.
Answers are grounded in this paper and cite their sources.
Oxidized LDL-regulated miRNAs offer potential as both therapeutic targets and early biomarkers for vascular endothelial dysfunction in atherosclerosis.
As a simple monolayer, vascular endothelial cells can respond to physicochemical stimuli. In addition to promoting the formation of foam cells, oxidized low-density lipoprotein (ox-LDL) contributes to the atherosclerotic process through different mechanisms, including endothelial cell dysfunction. As conserved noncoding RNAs, microRNAs (miRNAs) naturally lie in different genomic positions and post-transcriptionally regulate the expression of many genes. They participate in integrated networks formed under stress to maintain cellular homeostasis, vascular inflammation, and metabolism. These small RNAs constitute therapeutic targets in different diseases, including atherosclerosis, and their role as biomarkers is crucial given their detectability even years before the emergence of diseases. This review was performed to investigate the role of ox-LDL-regulated miRNAs in atherosclerosis, their molecular mechanisms, and their application as biomarkers of vascular endothelial cell dysfunction.
No takes yet. Share an insight, caveat, or question.
Kianmehr et al. (2021) conducted a review in Atherosclerosis. Oxidized LDL-regulated microRNAs was evaluated. Oxidized LDL-regulated miRNAs act as therapeutic targets and early biomarkers for assessing vascular endothelial dysfunction in atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: